Health tech ventures emerging from university ecosystems are moving from pilots to scaled use. MIT‑affiliated Otomo Health reports automating patient outreach and engagement for specialty clinics—handling tens of thousands of monthly interactions—and says the platform improves clinic throughput and revenue. Johns Hopkins’ Modelus won a $140,000 President’s Venture Fellowship and offers an AI analytics layer to standardize organoid experiments, cutting growth timelines and lab costs in pilot programs. Both companies illustrate how university labs and business schools are accelerating translational research and clinical operations—creating licensing, clinical‑trial, and placement opportunities for students in health care management and translational science programs.